Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost for Pulmonary Oxygenation During One-Lung Ventilation
NCT02784899Completed
- Sponsor
- Yonsei University
- Start
- Oct 2015
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of iloprost in lung cancer (2 arms), sponsored by Yonsei University. Primary endpoints: Partial Pressure of Arterial Oxygen Ratio and Incidence of Intrapulmonary Shunt. Started Oct 2015; status: completed.
02
Drugs
iloprost
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT02784899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02784899.